Molecular Templates, Inc. (NASDAQ: MTEM) today announced an agreement with Takeda Pharmaceutical Company Limited (Takeda) for the joint development of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE